XtalPi
XtalPi Inc., also known as XtalPi Holdings Limited, is a biotechnology company based in Shenzhen, China, with additional offices in the US and the UK. Founded in 2015 by three physicists from MIT, XtalPi focuses on enhancing drug discovery and material science research through the integration of artificial intelligence, quantum physics, and robotics. The company went public on the Hong Kong Stock Exchange in June 2024. XtalPi operates an Intelligent Digital Drug Discovery and Development (ID4/ID⁴) platform that combines computational and experimental approaches. Key offerings include XMolGen
Investing activity
XtalPi appears in 1 AI deal tracked by the AI Lounge deals desk, rounds totalling $50M, and led 1 of them. The rounds are mostly Seed, with a median round size of $50M. The most recent is Apex Intelligence (Angel (seed), $50M, Sep 2026).
XtalPi most often invests alongside Zhongguancun Science City, Xinglian Capital, IDG Capital and Shanghai Future Industry Fund, and the companies it backs on AI Lounge are mostly in AI.
Deals
Frequently asked questions about XtalPi
What AI companies has XtalPi invested in?
XtalPi's AI investments include Apex Intelligence. The 1 round on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is XtalPi based?
XtalPi is based in Cambridge, Massachusetts, United States.
What stage does XtalPi invest at?
In the rounds tracked on AI Lounge, XtalPi has invested at Seed, with a median round of $50M. XtalPi led 1 of those rounds.
Who does XtalPi co-invest with?
XtalPi's most frequent co-investors on AI Lounge are Zhongguancun Science City (1 deal), Xinglian Capital (1 deal), IDG Capital (1 deal), Shanghai Future Industry Fund (1 deal) and SCGC Group (1 deal).
How can founders reach XtalPi?
Founders on AI Lounge can see XtalPi's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add XtalPi to their Investor Pipeline to track the conversation.